Antibodies to TNFα

US8399627B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Christian Votsmeier · Cologne, DE
• Uwe Gritzan · Cologne, DE
• Kornelia Kirchner · Frechen, DE
• Michael Strerath
• Kerstin Baral · Mannheim, DE
• Ulrich Haupts · Halle (Saale), DE
• Wayne Coco · Cologne, DE
• Susanne Steinig · Cologne, DE
• Andreas Scheidig · Cologne, DE
• Klaus Pellengahr · Cologne, DE
• Simone Brückner · Cologne, DE
• Hanna Plittersdorf · Cologne, DE
• Peter Scholz · Cologne, DE
• Jan Tebbe · Cologne, DE

Key dates

• Filing date: Dec 24, 2008
• Grant date: Mar 19, 2013
• Expiry date: Apr 8, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are antibodies, antigen binding portions, and derivatives thereof that are capable of binding tumor necrosis factor alpha (TNFα); nucleic acids encoding the antibodies, antigen binding portions, and derivatives thereof, including complementary nucleic acids; vectors; and host cells containing the nucleic acids.